| 000 | 00947 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250517125231.0 | ||
| 264 | 0 | _c20181008 | |
| 008 | 201810s 0 0 eng d | ||
| 022 | _a1600-0641 | ||
| 024 | 7 |
_a10.1016/j.jhep.2016.11.007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHellard, Margaret | |
| 245 | 0 | 0 |
_aTargeted direct-acting antiviral treatment for chronic hepatitis C: A financial reality or an obstacle to elimination? _h[electronic resource] |
| 260 |
_bJournal of hepatology _c02 2017 |
||
| 300 |
_a270-272 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Research Support, Non-U.S. Gov't; Comment | ||
| 650 | 0 | 4 | _aAntiviral Agents |
| 650 | 0 | 4 | _aHepatitis C, Chronic |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aPedrana, Alisa | |
| 700 | 1 | _aScott, Nick | |
| 773 | 0 |
_tJournal of hepatology _gvol. 66 _gno. 2 _gp. 270-272 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jhep.2016.11.007 _zAvailable from publisher's website |
| 999 |
_c26637918 _d26637918 |
||